Results 181 to 190 of about 131,629 (255)

Incorporating latent survival trajectories and covariate heterogeneity in time-to-event data analysis: a joint mixture model approach. [PDF]

BMC Med Res Methodol
Liang FW, Chan W, Swartz MD, Dabaja BS.
europepmc   +1 more source

Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin\u27s lymphoma [PDF]

, 2018
Bartlett, N. L, et al,
core   +1 more source

Deucravacitinib in plaque psoriasis: Four‐year safety and efficacy results from the Phase 3 POETYK PSO‐1, PSO‐2 and long‐term extension trials

Journal of the European Academy of Dermatology and Venereology, EarlyView.
In this analysis of the long‐term safety and efficacy of deucravacitinib in patients with moderate to severe plaque psoriasis treated through 4 years, no new safety signals were observed compared with the first year. Patients continuously treated with deucravacitinib from Day 1 maintained clinical and patient‐reported outcome response rates.
April W. Armstrong, Mark Lebwohl, Richard B. Warren, Howard Sofen, Akimichi Morita, Carle Paul, Kim A. Papp, Matthew J. Colombo, Julie Scotto, John Vaile, Joe Zhuo, Eleni Vritzali, Victoria Berger, Georgene Schroeder, Subhashis Banerjee, Diamant Thaçi, Bruce Strober   +16 more
wiley   +1 more source

Cancer and Pregnancy [PDF]

, 1964
McGowan, Larry
core   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg, M. Kinberger, B. Arents, N. Aszodi, S. Barbarot, T. Bieber, H. A. Brough, P. Calzavara‐Pinton, S. Christen‐Zaech, M. Deleuran, M. Dittmann, N. Fosse, K. Gáspár, L. A. A. Gerbens, U. Gieler, G. Girolomoni, S. Gregoriou, S. Holland, C. G. Mortz, A. Nast, U. Nygaard, E. M. Rehbinder, J. Ring, M. Rossi, E. Serra‐Baldrich, D. Simon, Z. Z. Szalai, J. C. Szepietowski, A. Torrelo, T. Werfel, R. N. Werner, C. Flohr   +31 more
wiley   +1 more source

Socioeconomic, racial-ethnic, household, and infrastructural disparities of hematologic cancer outcomes in the United States. [PDF]

Blood Adv
Fei-Zhang DJ, Wu E, Stanisic AV, Hou L, Platanias LC, Ansell SM, Lewis-Thames MW, Badawy SM, Paludo J.   +8 more
europepmc   +1 more source

Prognosis of increasing percentages of lesional body surface area in early stage mycosis fungoides

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This study identifies a progressive decline in overall survival with each 10% increase in BSA in early‐stage mycosis fungoides. A new BSA cut‐off of 40% is proposed as a significant prognostic factor for patients with patch/plaque‐stage disease, with potential therapeutic consequences.
Juliette M. Kersten, Rosanne Ottevanger, Koen D. Quint, Maarten H. Vermeer, Jelle J. Goeman, Youn Kim, Felicity Evison, Julia J. Scarisbrick, Rein Willemze   +8 more
wiley   +1 more source

Primary Palatine Tonsil Non-Hodgkin Lymphoma in Western Romania: A Comparison of Lower-Stage and Advanced-Stage Disease. [PDF]

Hematol Rep
Morar R, Varga NI, Horhat DI, Mot IC, Balica NC, Tischer AA, Susan M, Susan R, Lighezan DL, Negrean RA.   +9 more
europepmc   +1 more source

Cancer and Accelerated Aging Research at the National Institutes of Health, 2013–2023: A Grant Portfolio Analysis

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background The purpose of this study was to describe the characteristics of the NIH‐funded grant portfolio focused on cancer and accelerated aging. Methods Research project grants focused on cancer survivors and aging trajectories that were newly funded during fiscal years 2013 through 2023 were identified by first using a text mining ...
Lisa Gallicchio, Rachelle Brick, Gina Tesauro, Lindsey Page, Paige Green, Jennifer L. Guida   +5 more
wiley   +1 more source